Replies to post #402610 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

I agree 100% sentiment stocks. Also, the fact that 1 of the Secondary Endpoints is still comparing the DCVax-L trial treatment group’s OS to the DCVax-L trial control group’s OS, speaks to and supports this fact as well.

The DCVax-L trial is a randomized control trial (RCT) that compares the OS of the DCVax-L treatment group to both the trial’s internal control group, and to ECAs. This trial’s analysis and results will give us the best of “both worlds”.

[Dr Bala]

Agreed.